Search

Walter C Darbonne

from Burlingame, CA
Age ~63
Get Report
Related to:
Jean Laird Sunn, 60Wayne Charles Darbonne, 63
Connected to:
Charles Darbonne, 92Kenneth C Darbonne, 39Maurice R Darbonnier, 75Melinda K Darbonne, 31Nicholas S Darbonne, 40Darnell Darbouze, 41Nina S Darbouze, 44Benjamin W Darbro, 48Brooke Darbro, 36Jeffrey N Darbut, 54

Walter Darbonne Phones & Addresses

  • Burlingame, CA
  • 443 25Th Ave, San Mateo, CA 94403 (650) 349-8916
  • Pacifica, CA
  • 443 W 25Th Ave, San Mateo, CA 94403 (510) 773-6722

Work

Company: Genentech Apr 1985 Position: Senior scientific manager, group leader and biomarker subteam leader

Education

Degree: Masters, Master of Arts School / High School: San Francisco State University 1986 to 1991 Specialities: Molecular Biology

Skills

Biomarkers • Biotechnology • Drug Discovery • Pharmacodynamics • Monoclonal Antibodies • Immunology • Assay Development • Drug Development • Elisa • Antibodies • Biopharmaceuticals • Protein Chemistry • Cell Culture • Cell • Cancer • Glp • Proteomics • Laboratory Automation • Cell Biology • Good Laboratory Practice

Emails

w***[email protected]

Industries

Biotechnology

Resumes

Resumes

Walter Darbonne Photo 1

Senior Scientific Manager, Group Leader And Biomarker Subteam Leader

View page
Location:
San Francisco, CA
Industry:
Biotechnology
Work:
Genentech
Senior Scientific Manager, Group Leader and Biomarker Subteam Leader
Education:
San Francisco State University 1986 - 1991
Masters, Master of Arts, Molecular Biology California Polytechnic State University - San Luis Obispo 1983 - 1984
Bachelors, Bachelor of Arts, Biochemistry
Skills:
Biomarkers
Biotechnology
Drug Discovery
Pharmacodynamics
Monoclonal Antibodies
Immunology
Assay Development
Drug Development
Elisa
Antibodies
Biopharmaceuticals
Protein Chemistry
Cell Culture
Cell
Cancer
Glp
Proteomics
Laboratory Automation
Cell Biology
Good Laboratory Practice

Publications

Us Patents

Use Of Human Epididymis Protein 4 (He4) For Assessing Responsiveness Of Muc 16-Positive Cancer Treatment

View page
US Patent:
20190233538, Aug 1, 2019
Filed:
Jan 4, 2019
Appl. No.:
16/239663
Inventors:
- South San Francisco CA, US
Daniel MASLYAR - San Carlos CA, US
Yulei WANG - South San Francisco CA, US
Walter DARBONNE - San Mateo CA, US
Eric HUMKE - Redwood City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07K 16/30
G01N 33/574
C07K 16/28
A61P 35/00
A61K 47/68
A61K 47/65
A61K 31/22
A61K 31/7048
Abstract:
The present invention relates to methods and kits or articles of manufacture related thereto that may find use, inter alia, in assessing responsiveness of cancers to MUC16 antagonists by monitoring HE4 expression. In some embodiments, the methods include measuring the level of expression of HE4 in a sample from a subject; comparing the level of expression of HE4 in the sample with the level of expression of HE4 in a sample previously obtained from the subject; and, optionally, administering to the subject a therapeutically effective amount of a MUC16 antagonist.
Control profile
Walter C Darbonne from Burlingame, CA, age ~63 Get Report